Background Advances in the diagnostic and therapeutic management of patients with
bloodstream infections (BSIs) have been achieved in the last years, improving clinical …

Infections due to multidrug-resistant pathogens have shown a dramatic worldwide increase
in prevalence. Bloodstream infections (BSIs) represent an important cause of morbidity and …

Background: Bloodstream infections (BSIs) are severe infections that can be community or
hospital acquired. Effects of time to appropriate treatment and impact of antimicrobial …

Background: Data on the effectiveness of definitive oral (PO) antibiotics for BSIs in
preparation for discharge from hospital are lacking, particularly for Gram-positive bacterial …

Bloodstream infection (BSI) is a frequent complication of invasive infections. The presence of
bacteremia has therapeutic and prognostic implications. Here we review recent changes in …

Objectives To define standardized endpoints to aid the design of trials that compare
antibiotic therapies for bloodstream infections (BSI). Methods Prospective studies …

Bloodstream infections (BSIs) represent a common complication among critically ill patients
and a leading cause of morbidity and mortality. The prompt initiation of an effective antibiotic …

Bloodstream infections (BSIs) in critically ill patients are associated with significant mortality.
For patients with septic shock, antibiotics should be administered within the hour …

Bacterial bloodstream infections (BSIs) are a major cause of morbidity and mortality in the
United States. Traditionally, BSIs have been managed with intravenous antimicrobials …

Bloodstream infections (BSI) are an indisputable cause of morbidity and mortality. These
infections may originate in the community setting among healthy individuals or among …